Table 4.

Percent changes in adolescent MRS per 1-unit increase in ln-transformed prenatal maternal urinary BPA.

Trimester of exposure	Adolescent metabolic syndrome risk score
	Model 1: Unadjusted				Model 2: A priori covariates
	N	BPA	MDS	BPA*MDS	N	BPA	MDS	BPA*MDS
		% Δ	% Δ	% Δ		% Δ	% Δ	% Δ
Entire sample
Trimester one	196	−0.101	0.000	0.009	189	−0.086	0.000	0.006
Trimester two	197	−0.324	−0.013	0.066	190	−0.324	−0.007	0.062
Trimester three	222	−0.139	0.032	0.016	206	−0.138	0.025	0.015
Females
Trimester one	106	−0.186	0.011	0.032	103	−0.215	−0.005	0.043
Trimester two	107	−0.113	0.047	0.012	104	−0.262	0.007	0.041
Trimester three	115	0.278	0.060	−0.058	112	0.391	0.044	−0.080
Males
Trimester one	90	0.174	−0.012	−0.059	86	0.436	0.024	−0.132
Trimester two	90	−0.043	−0.002	0.017	86	−0.728b	−0.025	0.152b
Trimester three	107	−0.422	0.006	0.070	103	−0.286	0.032	0.040

ABR: MRS: Metabolic Syndrome Risk Score; BPA: Bisphenol A; MDS: Mediterranean diet score Model 1: Unadjusted (only adjusted for trimester specific SG urinary BPA); Model 2: Maternal variables (adjusted for trimester specific SG urinary BPA, education level) and adolescent variables (pubertal status, urinary BPA and Mediterranean diet score adherence);

^ap < 0.05,

^bp < 0.10.